About
Colin Law is a partner in Fangda Partners’ Hong Kong office whose practice focuses on capital markets and securities transactions. He advises major investment banks and Chinese companies on international public offerings, takeovers, privatizations and regulatory matters, with particular involvement in the healthcare/biotech and media sectors, and serves on the Hong Kong Biomedical Development Advisory Panel.
Practice areas
Corporate / M&ACapital MarketsSecuritiesRegulatoryPrivate Equity
Office
Expertise
Healthcare & BiotechMediaCapital Markets (Equity)Takeovers and PrivatizationsRegulatory MattersFinancial Institutions
Education
- University of Hong Kong, PCLL
- University of Hong Kong, LL.B.
Admissions
- Admitted to practice in Hong Kong SAR (1993)
- Admitted to practice in England and Wales (1997)
Languages
EnglishMandarinCantonese